Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Anne Stilman"'
Autor:
Yu Chung Tsang, Anne Stilman, Anna Rozova, Caroline Fradette, Mark J. Allison, Fernando Tricta
Publikováno v:
Clinical Pharmacology in Drug Development. 7:22-32
This study evaluated whether deferiprone, an oral iron chelator, acts to prolong the QT interval. Fifty healthy volunteers received single doses of each of the following: therapeutic dose of deferiprone (33 mg/kg), supratherapeutic dose (50 mg/kg), p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29a9e09f41af769f72e1aa75a38b175b
https://doi.org/10.1002/cpdd.352
https://doi.org/10.1002/cpdd.352
Autor:
Fernando Tricta, Shalini Jayashankar, Yu Chung Tsang, Vincent Pichette, Eric Sicard, Caroline Fradette, Anne Stilman, Michael Spino
Publikováno v:
British Journal of Clinical Pharmacology
Aims In light of the growing recognition of renal disease in thalassemia, it is important to understand the impact of renal impairment on the pharmacokinetics of iron chelators. This study evaluated the pharmacokinetics and safety of the iron chelato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c184f0ee47922ce2bf6d404e68ef8e5
https://doi.org/10.1111/bcp.13037
https://doi.org/10.1111/bcp.13037
Autor:
M. A. Badr, Theresa Chan, Julie Kanter, Janet L. Kwiatkowski, Baba Inusa, Alshehri Abdulrahman, Suzan Williams, Michael Spino, Mohsen Saleh Elalfy, Fernando Tricta, Anna Rozova, David M. Lee, Mohamed Bejaoui, Anne Stilman, Fatma Soliman Elsayed Ebeid, Amal El-Beshlawy, Dian Shaw, Yurdanur Kilinç, Caroline Fradette, Yu-Chung Tsang, Jodie Sinclair, Mona Hamdy, Noemi Toiber Temin, Mônica Pinheiro de Almeida Veríssimo
Publikováno v:
Blood. 134:618-618
Background: Patients with sickle cell disease (SCD) or other rare anemias whose care includes chronic blood transfusions must receive iron chelation to prevent the morbidity of iron overload. Currently, only deferoxamine (DFO) and deferasirox (DFX) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d00ab8fc9909db3fcf8f3d5bdce254e
https://doi.org/10.1182/blood-2019-122062
https://doi.org/10.1182/blood-2019-122062
Autor:
Usama El-Safy, M. Akif Yesilipek, Yousryeia Abdel Rahman, Zakaria Al Hawsawi, Youssef Al-Tonbary, Ghazi Al Damanhouri, Shebl Said Shebl, Fernando Tricta, Yurdanur Kilinç, Mostafa A.S Salama, Zeynep Karakas, Mohamad H. Qari, Mohamed M. Badr, M Elalfy, Anne Stilman, Dilek Yazman, Noemi Toiber Temin, Yasser Wali
Publikováno v:
Pediatric Blood & Cancer. 61:879-884
Background A risk associated with the iron chelator deferiprone is the development of neutropenia or agranulocytosis. Accordingly, the product label recommends weekly blood monitoring and immediate interruption of treatment upon detection of an absol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0551706f0054578fe85dc27e7f3194b
https://doi.org/10.1002/pbc.24920
https://doi.org/10.1002/pbc.24920
Autor:
Mohssen, Elalfy, Yasser A, Wali, Mohamad, Qari, Ghazi, Al Damanhouri, Youssef, Al-Tonbary, Dilek, Yazman, Zakaria, Al Hawsawi, Zeynep, Karakas, Yurdanur, Kilinc, M Akif, Yesilipek, Mohamed, Badr, Usama, Elsafy, Mostafa, Salama, Yousryeia, Abdel Rahman, Shebl, Shebl, Anne, Stilman, Noemi, Toiber Temin, Fernando, Tricta
Publikováno v:
Pediatric bloodcancer. 61(5)
A risk associated with the iron chelator deferiprone is the development of neutropenia or agranulocytosis. Accordingly, the product label recommends weekly blood monitoring and immediate interruption of treatment upon detection of an absolute neutrop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0292bebcd58ec8df89ba355bdf7621c4
https://pubmed.ncbi.nlm.nih.gov/24376176
https://pubmed.ncbi.nlm.nih.gov/24376176
Autor:
Anne Stilman
How does good writing stand out?If its purpose is to convey facts, findings, or instructions, it need be read only once for its content to be clear. If its purpose is to entertain or to provoke thought, it makes readers want to come back for more.Rev
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.